Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric Emptying.

Chinmay S MaratheHung PhamTongzhi WuLaurence G TrahairRachael S RigdaMadeline D M ButtfieldSeva HatzinikolasKylie LangeChristopher K RaynerAndrea MariMichael HorowitzKaren Louise Jones

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)

NCT02308254.

Keyphrases

type diabetes
liver failure
respiratory failure
glycemic control
blood glucose
drug induced
aortic dissection
cardiovascular disease
extracorporeal membrane oxygenation
metabolic syndrome
weight loss